FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 99 filers reported holding FIVE PRIME THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $94,000 | -36.9% | 20,030 | -17.8% | 0.00% | -42.9% |
| Q2 2020 | $149,000 | +7.2% | 24,355 | -60.2% | 0.01% | -41.7% |
| Q1 2020 | $139,000 | -66.6% | 61,149 | -32.5% | 0.01% | -36.8% |
| Q4 2019 | $416,000 | +17.2% | 90,604 | -1.2% | 0.02% | +58.3% |
| Q3 2019 | $355,000 | -34.5% | 91,667 | +2.0% | 0.01% | -20.0% |
| Q2 2019 | $542,000 | +140.9% | 89,867 | +454.8% | 0.02% | +150.0% |
| Q3 2018 | $225,000 | -37.8% | 16,199 | -1.8% | 0.01% | -33.3% |
| Q4 2017 | $362,000 | -12.8% | 16,496 | +62.8% | 0.01% | -18.2% |
| Q3 2017 | $415,000 | +15.0% | 10,133 | -15.6% | 0.01% | 0.0% |
| Q2 2017 | $361,000 | +24.5% | 11,999 | +49.4% | 0.01% | +22.2% |
| Q1 2017 | $290,000 | +12.8% | 8,033 | +56.8% | 0.01% | +28.6% |
| Q4 2016 | $257,000 | -25.7% | 5,123 | -22.4% | 0.01% | -12.5% |
| Q3 2016 | $346,000 | -32.0% | 6,600 | -46.3% | 0.01% | -27.3% |
| Q2 2016 | $509,000 | -17.1% | 12,300 | -18.7% | 0.01% | -31.2% |
| Q1 2016 | $614,000 | +13.1% | 15,120 | +15.6% | 0.02% | +6.7% |
| Q4 2015 | $543,000 | +241.5% | 13,085 | +26.8% | 0.02% | +200.0% |
| Q3 2015 | $159,000 | -32.1% | 10,321 | +0.9% | 0.01% | -28.6% |
| Q1 2015 | $234,000 | – | 10,228 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|